 |
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail Molika Ashford. |
UK Study Suggests VEGF Splice Isoform Ratio Could Predict Colorectal Cancer Patients' Avastin Response
November 02, 2012
UK Study Suggests VEGF Splice Isoform Ratio Could Predict Colorectal Cancer Patients' Avastin Response
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Case Study Suggests FISH Test May Miss Some Patients Who Could Benefit from Crizotinib
September 12, 2012 / Pharmacogenomics Reporter - GenomeWeb Feature: The Rise of Lung Cancer Genetic Testing
May 8, 2013 / Pharmacogenomics Reporter - Amplion Research Report Suggests Review Times Longer, Approvals Fewer for MDx over 10 Years
April 17, 2013 / Pharmacogenomics Reporter - 20/20 GeneSystems Developing mTOR Pathway Test to Predict Herceptin Response in HER2-Positive Patients
September 19, 2012 / Pharmacogenomics Reporter - Biodesix Presents Data Showing Veristrat Useful for Identifying Avastin-Tarceva Responders
April 27, 2012 / ProteoMonitor